Sensus Healthcare, Inc.
SRTS
$4.53
$0.0751.69%
| Weiss Ratings | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B- | |||
| Rating Factors | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.88 | |||
| Price History | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.46% | |||
| 30-Day Total Return | -34.61% | |||
| 60-Day Total Return | -47.51% | |||
| 90-Day Total Return | -34.89% | |||
| Year to Date Total Return | -36.27% | |||
| 1-Year Total Return | 27.46% | |||
| 2-Year Total Return | -13.31% | |||
| 3-Year Total Return | -54.25% | |||
| 5-Year Total Return | 43.20% | |||
| 52-Week High % Change | -52.30% | |||
| 52-Week Low % Change | 52.92% | |||
| Price | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.33 | |||
| 52-Week Low Price | $2.91 | |||
| 52-Week Low Price (Date) | Mar 12, 2024 | |||
| 52-Week High Price (Date) | Nov 25, 2024 | |||
| Valuation | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 73.40M | |||
| Enterprise Value | 51.95M | |||
| Price/Earnings (TTM) | 11.04 | |||
| Earnings Per Share (TTM) | 0.40 | |||
| Earnings Per Share Growth | 1,493.28% | |||
| Price/Earnings To Growth | 0.01 | |||
| Price/Sales (TTM) | 1.75 | |||
| Price/Book (Q) | 1.31 | |||
| Enterprise Value/Revenue (TTM) | 1.24 | |||
| Price | $4.53 | |||
| Enterprise Value/EBITDA (TTM) | 6.24 | |||
| Enterprise Value/EBIT | 6.42 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 922 5808 | |||
| Address | 851 Broken Sound Parkway NW Boca Raton, FL 33487 | |||
| Website | sensushealthcare.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 19.35% | |||
| Profit Margin | 15.89% | |||
| Management Effectiveness | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.73% | |||
| Return on Equity | 12.70% | |||
| Income Statement | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 41.81M | |||
| Total Revenue (TTM) | 41.81M | |||
| Revenue Per Share | $2.54 | |||
| Gross Profit (TTM) | 24.43M | |||
| EBITDA (TTM) | 8.33M | |||
| EBIT (TTM) | 8.09M | |||
| Net Income (TTM) | 6.65M | |||
| Net Income Avl. to Common (TTM) | 6.65M | |||
| Total Revenue Growth (Q YOY) | 3.97% | |||
| Earnings Growth (Q YOY) | -63.28% | |||
| EPS Diluted (TTM) | 0.40 | |||
| EPS Diluted Growth (Q YOY) | -63.43% | |||
| Balance Sheet | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 22.06M | |||
| Cash Per Share (Q) | $1.34 | |||
| Total Current Assets (Q) | 56.74M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 55.83M | |||
| Current Ratio (Q) | 9.641 | |||
| Book Value Per Share (Q) | $3.38 | |||
| Total Assets (Q) | 62.17M | |||
| Total Current Liabilities (Q) | 5.89M | |||
| Total Debt (Q) | 602.00K | |||
| Total Liabilities (Q) | 6.34M | |||
| Total Common Equity (Q) | 55.83M | |||
| Cash Flow | SRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -276.00K | |||
| Cash from Financing (TTM) | 15.00K | |||
| Net Change in Cash (TTM) | -1.09M | |||
| Levered Free Cash Flow (TTM) | -1.11M | |||
| Cash from Operations (TTM) | -831.00K | |||
